WHO ICTRP trial

Detection of bone marrow metastases by FDG-PET/CT in patients with…

DRKS00030887 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00030887
Public title Detection of bone marrow metastases by FDG-PET/CT in patients with rhabdomyosarcomas
Scientific title Detection of bone marrow metastases by FDG-PET/CT in patients with rhabdomyosarcomas - KM Dx bei RMS
Primary sponsor Universitätsklinikum Freiburg, Kinder- und Jugendklinik, Klinik für Pädiatrische Hämatologie und Onkologie
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type observational
Countries Germany;France;Italy;Netherlands;United States
Conditions rhabdomyosarcoma
Interventions Group 1: Our retrospective analysis aims to re-evaluate FDG-PET/ CT images at initial diagnosis and reports of findings from bone marrow punctures at initial diagnosis in patients with rhabdomyosarcomas included in the SoTiSar registry…
Registration date Oct 3, 2025
Target size 300
Secondary IDs 22-1539-S1-retro
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations